Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Diethyl propane-1,3-diylbiscarbamate is a small molecule chemical compound classified as an ester of carbamic acid. It contains two carbamate groups linked by a propane-1,3-diyl moiety and has the molecular formula C9H18N2O4 with a molecular weight of approximately 218.25 g/mol. This compound is experimental and not approved for clinical use in any country. There are no known indications or marketed formulations for this drug. Its mechanism of action and pharmacological effects have not been described in available data sources.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on diethyl propane-1,3-diylbiscarbamate.